Evidence map›Paper›PMID 41952929›Full record

ArticleCureus2026

Reliability of the E-test and VITEK 2 Compact for Tigecycline Susceptibility Testing in Clinical Acinetobacter baumannii Isolates Compared With Broth Microdilution.

Amresh Pati, Bilal Ahmad Malik, Kavita Gupta, Ashoka Mahapatra

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amresh PatiMicrobiology, Kalinga Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
Bilal Ahmad MalikMicrobiology, Government Medical College, Kathua, Kathua, IND.
Kavita GuptaMicrobiology, Post Graduate Institute of Child Health, Noida, Noida, IND.
Ashoka MahapatraMicrobiology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe growing incidence of multidrug-resistant

objectiveThis study aims to determine the tigecycline susceptibility of clinical METHODOLOGIES: A total of 150 clinical isolates of

resultThe proportion of isolates categorized as susceptible by BMD was 90.67%, with MIC

conclusionDiscordant results have been observed across different susceptibility testing methods as well as using different interpretative criteria. As this study was conducted on a small number of isolates, additional studies are needed to determine an interpretation category for Indian isolates.

Indexed as

acinetobacter baumanniibroth microdilutione testtigecyclinevitek 2 compact

Identifiers

PMID41952929
PMCPMC13056267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.